ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,637, issued on Aug. 18, was assigned to RAMOT AT TEL-AVIV UNIVERSITY LTD. (Tel Aviv, Israel).
"Immunogenic compositions containing N-glycolylneuraminic acid bearing nanoparticles" was invented by Vered Padler-Karavani (Tel Aviv, Israel), Eliran Moshe Reuven (Tel Aviv, Israel) and Shani Leviatan Ben-Arye (Tel Aviv, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides an active cancer vaccine and specifically an immunogenic compositions of membrane vesicles that serve as biomimetic nanoparticles derived from eukaryotic cell membranes that bear N-glycolylneuraminic acid glycoconjugates. These compositions can elicit bene...